SUNZEN
Consolidated results for the financial period ended 31 Dec 2023
SUNZEN BIOTECH BERHAD |
Financial Year End | 30 Jun 2024 |
Quarter | Other |
Quarterly report for the financial period ended | 31 Dec 2023 |
The figures | have not been audited |
Remarks : |
The Company has changed its financial year end from 31 December to 30 June and the announcement on the change of financial year end has been made to Bursa Malaysia Securities Behad on 29 November 2023. Consequently, there was no comparative figure available for the financial period ended 31 December 2023. A copy of the interim financial report for the quarter ended 31 December 2022 is attached for reference purpose only. |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
Three Months
|
Three Months
|
Twelve Months
|
Twelve Months
|
||
01 Oct 2023
To |
01 Oct 2022
To |
01 Jan 2023
To |
01 Jan 2022
To |
||
31 Dec 2023
|
31 Dec 2022
|
31 Dec 2023
|
31 Dec 2022
|
||
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
1 | Revenue |
29,338
|
0
|
98,130
|
0
|
2 | Profit/(loss) before tax |
4,843
|
0
|
11,765
|
0
|
3 | Profit/(loss) for the period |
3,593
|
0
|
7,980
|
0
|
4 | Profit/(loss) attributable to ordinary equity holders of the parent |
3,110
|
0
|
6,798
|
0
|
5 | Basic earnings/(loss) per share (Subunit) |
0.44
|
0.00
|
0.96
|
0.00
|
6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.00
|
0.00
|
0.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.1800
|
0.1700
|
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | SUNZEN BIOTECH BERHAD |
Stock Name | SUNZEN |
Date Announced | 29 Feb 2024 |
Category | Financial Results |
Reference Number | FRA-27022024-00086 |